Mercury Laboratories Quarterly Results for Trading Insights
MERCURYLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹3 Cr
QMarch 2025
Mercury Laboratories Quarterly Results Key Highlights
- Revenue of ₹76 Cr in March 2025 (+0.0% vs March 2025, -1.3% vs March 2024)
- Net Profit of ₹3 Cr in March 2025 (+0.0% vs March 2025, -50.0% vs March 2024)
- EBITDA of ₹8 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 9.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹26.21 in March 2025 (+0.0% vs March 2025)
Mercury Laboratories Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 79 | 76 | 77 | 77 | 59 | 3.9% | - |
| Net Profit (₹ Cr) | 5 | 3 | 6 | 6 | 4 | - | - |
| EBITDA (₹ Cr) | 10 | 8 | 10 | 10 | 8 | - | - |
| EPS (₹) | 40.90 | 26.21 | 47.12 | 46.49 | 29.68 | - | - |
| Operating Margin (%) | 11.0% | 9.0% | 12.0% | 11.0% | 12.0% | - | - |
Mercury Laboratories Share Price Trend Around Quarterly Results
Visualize Mercury Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Mercury Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Mercury Laboratories
Additional stock information and data for MERCURYLAB
Revenue Trend (₹ Cr)
March 2023
77
March 2024
77
March 2025
76
2026
79
Net Profit Trend (₹ Cr)
March 2023
6
March 2024
6
March 2025
3
2026
5
Operating Margin Trend (%)
March 2023
11.0%
March 2024
12.0%
March 2025
9.0%
2026
11.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Mercury Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹412,613.60 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,570.84 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores